Effect of debrisoquin, guanethidine and tyramine on platelet function and blood coagulation.
D000227:Adenine Nucleotides / Q000494:pharmacology; D000578:Amidines / Q000494:pharmacology*; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001773:Blood Cells / Q000187:drug effects; D001777:Blood Coagulation / Q000187:drug effects*; D001779:Blood Coagulation Factors; D001792:Blood Platelets / Q000032:analysis / Q000187:drug effects*; D002449:Cell Aggregation / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects; D005898:Glass; D006145:Guanethidine / Q000494:pharmacology*; D007546:Isoquinolines / Q000494:pharmacology*; D008297:Male; D010973:Platelet Adhesiveness / Q000187:drug effects; D011517:Prothrombin Time; D011817:Rabbits; D012701:Serotonin / Q000378:metabolism; D012911:Snakes; D013634:Tannins / Q000494:pharmacology; D013925:Thromboplastin / Q000378:metabolism; D014439:Tyramine / Q000494:pharmacology*; D014688:Venoms / Q000494:pharmacology
D000227:Adenine Nucleotides; D000578:Amidines; D000959:Antihypertensive Agents; D001779:Blood Coagulation Factors; D007546:Isoquinolines; D013634:Tannins; D014688:Venoms; D012701:Serotonin; D013925:Thromboplastin; D014439:Tyramine; D006145:Guanethidine